Stratec SE
Stratec SE (STSEY) Financial Performance & Income Statement Overview
Analyze Stratec SE (STSEY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Stratec SE (STSEY) Income Statement & Financial Overview
View the income breakdown for Stratec SE STSEY across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $81.32M | $57.23M | $68.20M | $50.87M |
| Cost of Revenue | $51.84M | $40.70M | $50.88M | $37.81M |
| Gross Profit | $29.48M | $16.52M | $17.32M | $13.06M |
| Gross Profit Ratio | $0.36 | $0.29 | $0.25 | $0.26 |
| R&D Expenses | $3.49M | $2.56M | $2.96M | $2.60M |
| SG&A Expenses | $8.30M | $10.50M | $8.78M | $9.33M |
| Operating Expenses | $11.24M | $14.30M | $11.74M | $10.91M |
| Total Costs & Expenses | $63.08M | $55.008M | $62.62M | $49.74M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.41M | $1.39M | $1.19M | $1.55M |
| Depreciation & Amortization | $5.10M | $4.86M | $4.83M | $4.65M |
| EBITDA | $23.07M | $7.08M | $10.40M | $6.80M |
| EBITDA Ratio | $0.28 | $0.12 | $0.15 | $0.13 |
| Operating Income | $18.24M | $2.22M | $5.59M | $1.13M |
| Operating Income Ratio | $0.22 | $0.04 | $0.08 | $0.02 |
| Other Income/Expenses (Net) | -$2.05M | -$1.39M | -$1.20M | -$529000.00 |
| Income Before Tax | $16.19M | $832000.00 | $4.39M | $601000.00 |
| Income Before Tax Ratio | $0.20 | $0.01 | $0.06 | $0.01 |
| Income Tax Expense | $4.64M | $283000.00 | $914000.00 | $154000.00 |
| Net Income | $11.55M | $549000.00 | $3.48M | $447000.00 |
| Net Income Ratio | $0.14 | $0.010 | $0.05 | $0.009 |
| EPS | $0.95 | $0.05 | $0.29 | $0.04 |
| Diluted EPS | $0.95 | $0.05 | $0.29 | $0.04 |
| Weighted Avg Shares Outstanding | $12.16M | $12.16M | $12.16M | $12.16M |
| Weighted Avg Shares Outstanding (Diluted) | $12.16M | $12.16M | $12.16M | $12.16M |
Financial performance has remained strong, with revenue growing from $50.87M in Q1 2024 to $81.32M in Q4 2024. Gross profit continued to perform well, with margins at 36% in the latest quarter. Operating income reached $18.24M in Q4 2024, holding a steady 22% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $23.07M. Net income rose to $11.55M, keeping EPS at $0.95. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan